The Deubiquitinase A20 Mediates Feedback Inhibition of Interleukin-17 Receptor Signaling
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
The proinflammatory cytokine interleukin-17 (IL-17) is the signature cytokine of the T helper 17 (TH17) subset of CD4(+) T cells, and antibodies targeting IL-17 or the IL-17 receptor (IL-17R) show clinical efficacy in several autoimmune diseases. Although important for protective immunity against microorganisms, IL-17 causes collateral damage in inflammatory settings. TNFAIP3 encodes the deubiquitinase A20 and is genetically linked to numerous autoimmune syndromes. A20, a potent inhibitor of tumor necrosis factor-α signaling, removes ubiquitin from signaling intermediates upstream of nuclear factor κB (NF-κB), thereby dampening NF-κB-mediated inflammation. We demonstrated that IL-17 stimulates TNFAIP3 expression. Enhanced IL-17-mediated induction of genes encoding proinflammatory factors, including IL-6 and various chemokines, occurred upon knockdown of A20 with short inhibitory RNA or in A20(-/-) cells. A20 associated with the E3 ubiquitin ligase TRAF6 (tumor necrosis factor receptor-associated factor 6) in an IL-17-dependent manner and restricted the IL-17-dependent activation of NF-κB and mitogen-activated protein kinases. A20 interacted directly with the distal domain of IL-17RA, a previously defined inhibitory domain. Together, these data describe a mechanism of restraining IL-17 signaling and reveal an aspect of A20 activity that may help to explain its role in autoimmunity in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IL-17-NF-κB signaling induces several negative feedback circuits that restrain NF-κB activation, including deubiquitinating enzymes or related factors, including A20 (TNFAIP3), Abin-1 (TNIP1) and USP25”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Garg et al., 2013
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873 · cited 2×
“IL-17 is produced by a subset of CD4 T cells termed T helper 17 (TH17) cells, and a fast-moving body of literature has described the many mechanisms by which TH17 cells are generated and regulated (6, 7).”
BackgroundHarrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039 · cited 1×
“Conversely, excess IL-17 is associated with numerous autoimmune diseases, and many genes identified as risk loci for autoimmunity in genome-wide association studies (GWAS) (for example, IL23R and STAT3) are associated with regulation of IL-17 or the TH17 differentiation pathway (13, 14).”
BackgroundCytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2094 · Cited by 2,529 · cited 1×
“Inflammatory cytokines, such as tumor necrosis factor–a (TNF-a), have long been recognized to promote the pathogenesis of devastating autoimmune diseases, such as rheumatoid arthritis (RA), among many others (1).”
BackgroundDe-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,856 · cited 3×
“The primary enzymatic function of A20 is to serve as a DUB, although it can also act as a ubiquitin ligase and inhibit signaling independently of its catalytic activity (32, 36, 55, 80).”
BackgroundSelf-citationIL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842 · cited 1×
“Since the discovery of the TH17 subset of helper T cells in 2005, considerable attention has been paid to how TH17 and other IL-17–producing cells are generated and maintained but far less to how IL-17 mediates downstream signaling (6, 62).”
BackgroundInnate IL-17-producing cells: the sentinels of the immune system
Cua, D. J., & Tato, C. M. (2010) · Nature Reviews Immunology · doi:10.1038/nri2800 · Cited by 1,578
Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation
Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., Blank, R. B., Meylan, F., Siegel, R., Hennighausen, L., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.009 · Cited by 1,507
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475 · cited 8×
“A20 inhibits the IL-17–dependent activation of MAPK signaling, particularly the c-Jun N-terminal kinase pathway In the IL-17 signaling pathway, TRAF6 is required for the activation of MAPKs (15).”
BackgroundSelf-citation
Cited by
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
Self-citationThe IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“Conversely, IL-17-NF-κB signaling induces several negative feedback circuits that restrain NF-κB activation, including deubiquitinating enzymes or related factors, including A20 (TNFAIP3), Abin-1 (TNIP1) and USP25 (Cruz et al., 2017; Garg et al., 2013; Zhong et al., 2012) (Figure 4).”
BackgroundSelf-citationIL-17 and IL-17-producing cells in protection versus pathology
Mills, K. H. G. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00746-9 · Cited by 1,000
IL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785
“In the IL-17 pathway, A20 (encoded by Tnfaip3, a common autoimmune gene locus [99]) and Usp25 have both been shown to deubiquitinate TRAFs (Figure 4) [42, 103].”
BackgroundSelf-citationNF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration
Dorrington, M. G., & Fraser, I. D. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00705 · Cited by 717
“Moreover, even in the presence of continued stimulation, negative regulation via deubiquitinases like A20 can arrest signaling by deubiquitinating both components of the IKK complex (38) and important signaling proteins such as TRAF6 (39).”
BackgroundChung, L., Thiele Orberg, E., Geis, A. L., Chan, J. L., Fu, K., DeStefano Shields, C. E., Dejea, C. M., Fathi, P., Chen, J., Finard, B. B., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.01.007 · Cited by 644
“We did not find significant ETBF-mediated changes in expression of either Tnfaip3 that encodes the deubiquitinase, A20, a negative regulator of IL-17R (Garg et al., 2013) or Elavl1 encoding the protein Hur (Herjan et al.”
IL-17 family: Cytokines, receptors and signaling
Gu, C., Wu, L., & Li, X. (2013) · Cytokine · doi:10.1016/j.cyto.2013.07.022 · Cited by 595
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript and MAPK cascades, TRAF2 and TRAF5 are involved in IL-17A-dependent mRNA stabilization through the activation of IKKi.”
BackgroundInfluentialIL-17 receptor–based signaling and implications for disease
Li, X., Bechara, R., Zhao, J., McGeachy, M. J., & Gaffen, S. L. (2019) · Nature Immunology · doi:10.1038/s41590-019-0514-y · Cited by 548
Self-citationA20 in inflammation and autoimmunity
Catrysse, L., Vereecke, L., Beyaert, R., & van Loo, G. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.10.005 · Cited by 493
The IL-17 family in diseases: from bench to bedside
Huangfu, L., Li, R., Huang, Y., & Wang, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01620-3 · Cited by 452
“59,60 Similarly, ubiquitin-speci fi c peptidase 25 (USP25) can deubiquitinate TRAF6, thereby blocking the IL-17 signaling pathway.”
BackgroundA Metabolite-Triggered Tuft Cell-ILC2 Circuit Drives Small Intestinal Remodeling
Schneider, C., O’Leary, C. E., von Moltke, J., Liang, H.-E., Ang, Q. Y., Turnbaugh, P. J., Radhakrishnan, S., Pellizzon, M., Ma, A., & Locksley, R. M. (2018) · Cell · doi:10.1016/j.cell.2018.05.014 · Cited by 478
“The signaling component of the IL-25 receptor, IL-17RA, and its adaptor proteins are negatively regulated by A20 (Tnfaip3) (Garg et al., 2013).”
Self-citationWalsh, M. C., Lee, J., & Choi, Y. (2015) · Immunological Reviews · doi:10.1111/imr.12302 · Cited by 438
“In other cases TRAF6 is linked to the receptor via intermediary proteins, such as Act1 for the IL-17R family, the MALT1-CARMA1-Bcl-10 complex downstream of TCR, the MyD88-IRAK4-IRAK1/2 complex downstream of some TLR/IL-1R superfamily members (e.g., TLR7/8/9, TLR2/4, IL-1/18/33R), and TRIF for others (e.g., TLR3/4).”
The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
Liu, T., Li, S., Ying, S., Tang, S., Ding, Y., Li, Y., Qiao, J., & Fang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594735 · Cited by 386
“TRAF6, in combination with A20 (an anti-inflammatory protein) when presented, blocks the activation of NF-kB and MAPK to negatively regulate IL-17 signaling (35).”
BackgroundMonin, L., & Gaffen, S. L. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028522 · Cited by 339
“The deubiquitinase A20 is induced downstream of IL-17A and dampens the activation of NF-kB and MAPK pathways by removal of K63-linked ubiquitin chains on TRAF6 (Garg et al. 2013).”
BackgroundSelf-citationIL‐17: overview and role in oral immunity and microbiome
Abusleme, L., & Moutsopoulos, N. (2017) · Oral Diseases · doi:10.1111/odi.12598 · Cited by 183
“The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling.”
IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases
Song, X., & Qian, Y. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.07.021 · Cited by 162
IL-17 in the immunopathogenesis of spondyloarthritis
Taams, L. S., Steel, K. J. A., Srenathan, U., Burns, L. A., & Kirkham, B. W. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0044-2 · Cited by 158
Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases
Chen, J., Liu, X., & Zhong, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.566922 · Cited by 165
“However, IL-17- NFκB signaling induces several negative feedback circuits to restrain the activation of NF-κB, such as deubiquitination (Garg et al., 2013; Cruz et al., 2017).”
BackgroundGarg, A. V., Amatya, N., Chen, K., Cruz, J. A., Grover, P., Whibley, N., Conti, H. R., Hernandez Mir, G., Sirakova, T., Childs, E. C., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.021 · Cited by 145
“A20 and USP25 downregulate TRAF6, limiting NF-kB and MAPK activation (Garg et al., 2013; Zhong et al., 2012).”
InfluentialSelf-citationThe roles and functional mechanisms of interleukin-17 family cytokines in mucosal immunity
Song, X., He, X., Li, X., & Qian, Y. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.105 · Cited by 137
TRAF Molecules in Inflammation and Inflammatory Diseases
Lalani, A., Zhu, S., Gokhale, S., Jin, J., & Xie, P. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0117-y · Cited by 132
The Dark Side of Cell Signaling: Positive Roles for Negative Regulators
Lemmon, M. A., Freed, D. M., Schlessinger, J., & Kiyatkin, A. (2016) · Cell · doi:10.1016/j.cell.2016.02.047 · Cited by 115
“A20 has also been reported to interact directly with the IL-17 receptor IL-17RA to provide a more direct negative feedback loop (Garg et al., 2013) and can inhibit interaction of several of the E3 ubiquitin ligases involved in promoting NF-kB signaling with their E2 enzymes (Shembade et al.”
Much More Than IL-17A: Cytokines of the IL-17 Family Between Microbiota and Cancer
Brevi, A., Cogrossi, L. L., Grazia, G., Masciovecchio, D., Impellizzieri, D., Lacanfora, L., Grioni, M., & Bellone, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.565470 · Cited by 121
“For instance, upregulation of IL-17 signaling via NFkB is associates with susceptibility to autoimmune syndromes, including psoriasis and experimental autoimmune encephalomyelitis (78, 79).”
BackgroundTRAF Regulation of IL-17 Cytokine Signaling
Swaidani, S., Liu, C., Zhao, J., Bulek, K., & Li, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01293 · Cited by 110
“USP25 and A20 (44) both function as deubiquitinase enzymes or DUBs that target K63-linked polyubiquitination of TRAF6 and mediate the negative feedback regulation of IL-17 induced NFkB and MAPK.”
BackgroundThe role of interleukin-17 in asthma: a protective response?
Hynes, G., & Hinks, T. (2020) · ERJ Open Research · doi:10.1183/23120541.00364-2019 · Cited by 103
Dainichi, T., Matsumoto, R., Mostafa, A., & Kabashima, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01107 · Cited by 96
“TAK1 is also involved in the activation of MAPKs and a transcription factor, activating protein-1 (AP-1), as described in the next section.”
BackgroundInfluentialTh17 Cells in Periodontitis and Its Regulation by A20
Huang, N., Dong, H., Luo, Y., & Shao, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742925 · Cited by 100
“On the C-terminal of IL17RA, CBAD is indispensable to the activation, translation and phosphorylation of C/EBPb and negatively controls IL-17induced signaling (27).”
BackgroundInfluentialKeratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function
Ippagunta, S. K., Gangwar, R., Finkelstein, D., Vogel, P., Pelletier, S., Gingras, S., Redecke, V., & Häcker, H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606996113 · Cited by 85
“Interestingly, A20 has been shown to counteract IL-17R–mediated signaling, at least in cell lines in vitro (47).”
BackgroundMCPIP1/Regnase-1 Restricts IL-17A- and IL-17C-Dependent Skin Inflammation
Monin, L., Gudjonsson, J. E., Childs, E. E., Amatya, N., Xing, X., Verma, A. H., Coleman, B. M., Garg, A. V., Killeen, M., Mathers, A., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601551 · Cited by 82
“The deubiquitinase A20 (TNFAIP3) is induced by IL-17A and mediates the removal of K63-linked ubiquitin chains on TRAF6, tempering activation of NF-kB and MAPK pathways (56).”
BackgroundSelf-citationInhibiting RORγt/Th17 axis for autoimmune disorders
Isono, F., Fujita-Sato, S., & Ito, S. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.04.012 · Cited by 82
Shuai, C., Yang, X., Pan, H., & Han, W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.582863 · Cited by 79
“Overexpression of CXCL10 is considered to be a favorable prognostic factor in TNBC (44), and high levels of TNFAIP3 expression are correlated with poor overall survival in HER2+ breast cancer and TNBC (45).”
BackgroundInfluentialWu, N., Huang, D.-Y., Tsou, H.-N., Lin, Y., & Lin, W. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.383 · Cited by 76
Song, M., Liang, J., Wang, L., Li, W., Jiang, S., Xu, S., Tang, L., Du, Q., Liu, G., Meng, H., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110757 · Cited by 74
Th17 Differentiation and Their Pro-inflammation Function
Song, X., Gao, H., & Qian, Y. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-9487-9_5 · Cited by 74
“More recently, A20, another deubiquitinating enzyme, was identified as a negative regulator of IL-17A induced NF-κB and MAPK activation [69].”
BackgroundInfluentialMimpen, J. Y., Baldwin, M. J., Cribbs, A. P., Philpott, M., Carr, A. J., Dakin, S. G., & Snelling, S. J. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.676173 · Cited by 69
Ciccacci, C., Latini, A., Perricone, C., Conigliaro, P., Colafrancesco, S., Ceccarelli, F., Priori, R., Conti, F., Perricone, R., Novelli, G., et al. (2019) · Journal of Immunological Research · doi:10.1155/2019/6728694 · Cited by 62
Devos, M., Mogilenko, D. A., Fleury, S., Gilbert, B., Becquart, C., Quemener, S., Dehondt, H., Tougaard, P., Staels, B., Bachert, C., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.06.191 · Cited by 67
A20: a master regulator of arthritis
Wu, Y., He, X., Huang, N., Yu, J., & Shao, B. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02281-1 · Cited by 58
“the prolonged phosphorylation of c-Jun-N-terminalkinase (JNK), which are both important for MAPK activation [46].”
BackgroundMeng, Z., Zhao, T., Zhou, K., Zhong, Q., Wang, Y., Xiong, X., Wang, F., Yang, Y., Zhu, W., Liu, J., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600334 · Cited by 55
Th17 Cells in Helicobacter pylori Infection: a Dichotomy of Help and Harm
Dixon, B. R. E. A., Hossain, R., Patel, R. V., & Algood, H. M. S. (2019) · Infection and Immunity · doi:10.1128/iai.00363-19 · Cited by 58
“Since IL-17 upregulates A20 expression, this demonstrates that this pathway of regulation is an established negative feedback loop that restricts IL-17-driven inflammation (96).”
BackgroundAbbasi, A., Forsberg, K., & Bischof, F. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00021 · Cited by 56
“Indeed, A20 was shown to attenuate TLR-4/LPS, TNFα, IL-1, IL-17, and NOD2 induced NF-κB signaling by disassembling the lys63-linked polyubiquitin chains from RIP1, RIP2, TRAF6, and NEMO (Boone et al., 2004; Wertz et al., 2004; Hitotsumatsu et al., 2008; Garg et al., 2013).”
BackgroundSousa, G. R., Gomes, J. D. A. S., Damasio, M. P. S., Nunes, M. C. P., Costa, H. S., Medeiros, N. I., Fares‐Gusmao, R., Chaves, A. T., Corrêa‐Oliveira, R., & Rocha, M. O. D. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172833 · Cited by 50
FXYD3 enhances IL-17A signaling to promote psoriasis by competitively binding TRAF3 in keratinocytes
Yang, W., He, R., Qu, H., Lian, W., Xue, Y., Wang, T., Lin, W., Zhu, P., Xia, M., Lai, L., et al. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-00973-7 · Cited by 52
“TRAF3 and A20, two signaling inhibitors, have similarly been reported to associate with the CBAD domain [25, 36].”
BackgroundUrbano, P. C. M., Aguirre‐Gamboa, R., Ashikov, A., van Heeswijk, B., Krippner‐Heidenreich, A., Tijssen, H. J., Li, Y., Azevedo, V. F., Smits, L. J. T., Hoentjen, F., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.11.024 · Cited by 44
An Organismal Model for Gene Regulatory Networks in the Gut-Associated Immune Response
Buckley, K. M., & Rast, J. P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01297 · Cited by 47
“In addition, reduced expression was also evident for two IL17 target genes in vertebrates: tumor necrosis factor α induced protein 3 (tnfaip3; also known as A20), which encodes a ubiquitin-editing enzyme that inhibits NF-κB activation (61), and NF-κB inhibitor ζ (nfkbiz), an IL17 target gene in vertebrates that also r…”
Interleukin-17A in lipid metabolism and atherosclerosis
Yu, X., Jiang, N., Zheng, X., Cayabyab, F. S., Tang, Z.-B., & Tang, C. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.012 · Cited by 42
Immunopathogenesis and distinct role of Th17 in periodontitis: A review
Kini, V. V., Mohanty, I. R., Telang, G., & Vyas, N. (2022) · Journal of Oral Biosciences · doi:10.1016/j.job.2022.04.005 · Cited by 41
Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses
Bishu, S., Su, E. W., Wilkerson, E. R., Reckley, K. A., Jones, D. M., McGeachy, M. J., Gaffen, S. L., & Levesque, M. C. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4480 · Cited by 38
“Genome-wide association study data point to a role for the Th17/IL-17 axis in RA, as risk alleles impact Th17 generation and maintenance (IL6R, IL2, IL21, TYK2), trafficking (CCR6) or IL-17A signal transduction (TNFAIP3) [24,25].”
BackgroundSelf-citationSystematic analysis of the IL ‐17 receptor signalosome reveals a robust regulatory feedback loop
Draberova, H., Janusova, S., Knizkova, D., Semberova, T., Pribikova, M., Ujevic, A., Harant, K., Knapkova, S., Hrdinka, M., Fanfani, V., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104202 · Cited by 35
“Murine IL-17 binds first strongly to IL-17RA and only subsequently can interact with IL-17RC to form the complex in 1:2:1 stoichiometry between IL-17RA: IL-17:IL-17RC (Ely et al , 2009; Liu et al , 2013; Goepfert et al , 2017).”
InfluentialIL‐17 in intervertebral disc degeneration: Mechanistic insights and therapeutic implications
Tan, J., Li, Z., Liu, L., Liu, H., & Xue, J. (2022) · Cell Biology International · doi:10.1002/cbin.11767 · Cited by 34
“After binding to the distal region of IL‐17RA, A20 removes the ubiquitination of TRAF6 to restrict IL‐17‐mediated NF‐κB and MAPK activation (Garg et al., 2013).”
BackgroundInfluentialTargeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges
Jin, W., Mao, X., & Qiu, G. (2016) · Medicinal Research Reviews · doi:10.1002/med.21421 · Cited by 34
Xian, J., Zeng, Y., Chen, S., Lu, L., Liu, L., Chen, J., Rao, B., Zhao, Z., Liu, J., Xie, C., et al. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab034 · Cited by 32
In situ antitumor vaccination: Targeting the tumor microenvironment
Li, H., Yu, J., Wu, Y., Shao, B., & Wei, X. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29551 · Cited by 35
IL-17-driven intestinal fibrosis is inhibited by Itch-mediated ubiquitination of HIC-5
Paul, J., Singh, A. K., Kathania, M., Tsakem, E. L., Zeng, M., Basrur, V., Theiss, A. L., & Venuprasad, K. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.53 · Cited by 32
RKIP mediates autoimmune inflammation by positively regulating IL‐17R signaling
Lin, W., Wang, N., Zhou, K., Su, F., Jiang, Y., Shou, J., Liu, H., Ma, C., Qian, Y., Wang, K., et al. (2018) · EMBO Reports · doi:10.15252/embr.201744951 · Cited by 32
“Researchers have made a concerted effort to construct a detailed map of IL-17R-mediated signaling events [13,33,39,40]; however, the upstream mediators of IL-17R-mediated signaling remain unclear.”
Wu, H., Tsai, L., Huang, C.-K., Hsu, P., Chen, M., Chen, Y. M., Hu, C., Shen, C., Lee, C., Chang, M., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc2823 · Cited by 34
Lambert, S., Swindell, W. R., Tsoi, L. C., Stoll, S. W., & Elder, J. T. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.12.032 · Cited by 32
“As might be expected given its key role in inflammation, IL-17 signaling is subject to several levels of feedback regulation (Garg et al., 2013), including one involving the ribonuclease MCPIP1 encoded by ZC3H12A (Garg et al.”
BackgroundIL-17 Signaling Triggers Degradation of the Constitutive NF-κB Inhibitor ABIN-1
Cruz, J. A., Childs, E. E., Amatya, N., Garg, A. V., Beyaert, R., Kane, L. P., Aneskievich, B. J., Ma, A., & Gaffen, S. L. (2017) · ImmunoHorizons · doi:10.4049/immunohorizons.1700035 · Cited by 29
“In prior work, we found that A20 is part of a feedback loop that restricts IL-17–mediated TRAF6 ubiquitination, which is required for NF-kB andMAPK activation; this finding prompted the present analyses of the A20-binding protein ABIN-1 (7).”
BackgroundMethodResultSelf-citationE3 ubiquitin ligase NEDD4L negatively regulates inflammation by promoting ubiquitination of MEKK2
Li, H., Wang, N., Jiang, Y., Wang, H., Xin, Z., An, H., Pan, H., Ma, W., Zhang, T., Wang, X., et al. (2022) · EMBO Reports · doi:10.15252/embr.202254603 · Cited by 32
“Several IL-17R signaling negative regulators have been reported, including TRAF3, USP25, A20, SCF b -TrCP , and GSK-3 b (Zhong et al , 2012; Garg et al , 2013) (Shen et al , 2009; Zhu et al , 2010; Shi et al , 2011).”
Wang, S.-A., Wang, Y.-C., Chuang, Y.-P., Huang, Y.-H., Su, W., Chang, W.-C., & Hung, J.-J. (2016) · Oncogene · doi:10.1038/onc.2016.445 · Cited by 31
A20 Orchestrates Inflammatory Response in the Oral Mucosa through Restraining NF-κB Activity
Li, Y., Mooney, E. C., Holden, S. E., Xia, X., Cohen, D. J., Walsh, S. W., Ma, A. I., & Sahingur, S. E. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801286 · Cited by 31
Self-citationPro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes
Choi, H., & Baek, K. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04132-5 · Cited by 28
“USP is reported to be involved in many diseases, including cancer proliferation, inflammation, and neurodegenerative disorders [28, 29].”
BackgroundJiang, Y., Wang, W., Zheng, X., & Jin, H. (2020) · Journal of Immunology Research · doi:10.1155/2020/5980190 · Cited by 26
“Garg et al. showed that TNFAIP3 suppressed activation of the MAPK pathway [23].”
Variants of ubiquitin-specific peptidase 24 play a crucial role in lung cancer malignancy
Wang, Y.-C., Wang, S.-A., Chen, P.-H., Hsu, T.-I., Yang, W., Chuang, Y.-P., Su, W., Liaw, H., Chang, W.-C., & Hung, J.-J. (2015) · Oncogene · doi:10.1038/onc.2015.432 · Cited by 26
Denk, D., Ramakrishnan, M., Conche, C., Pallangyo, C. K., Pesic, M. H., Ceteci, F., Kennel, K. B., Kirisözü, A. C., Engel, E., Mohs, K., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.02.005 · Cited by 25
Innate Lymphoid Cells in Helminth Infections—Obligatory or Accessory?
Löser, S., Smith, K. A., & Maizels, R. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00620 · Cited by 29
“The activation of intestinal ILC2s by IL25 is negatively regulated by the deubiquitinase A20 (Tnfaip3), which binds and inhibits the IL-25 receptor subunit IL-17RA (48).”
BackgroundHo, A. W., Garg, A. V., Monin, L., Simpson-Abelson, M. R., Kinner, L. B., & Gaffen, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070168 · Cited by 26
“This domain corresponds to the C/EBPb-activation domain (CBAD) in IL-17RA [49,56], which was previously linked to inhibitory signaling [24,36,39,57].”
BackgroundInfluentialSelf-citationNolin, J. D., Tully, J. E., Hoffman, S. M., Guala, A. S., van der Velden, J. L. J., Poynter, M. E., van der Vliet, A., Anathy, V., & Janssen-Heininger, Y. M. W. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.04.028 · Cited by 27
“A recent study demonstrated the importance of A20 in negative feedback regulation of IL-17A-induced cellular responses [60].”
BackgroundShao, B., Wei, X., Luo, M., Yu, J., Tong, A., Ma, X., Ye, T., Deng, H., Sang, Y., Liang, X., et al. (2015) · Scientific Reports · doi:10.1038/srep16437 · Cited by 22
Hypomorphic A20 expression confers susceptibility to psoriasis
Aki, A., Nagasaki, M., Malynn, B. A., Ma, A. I., & Kagari, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180481 · Cited by 24
Self-citationSaxena, S., Lokhande, H. A., Gombolay, G. Y., Raheja, R., Rooney, T., & Chitnis, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-69182-w · Cited by 23
Ma, X., Wang, D., Li, N., Gao, P., Zhang, M., & Zhang, Y. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.10.005 · Cited by 22
“IL-17 binds to a heterodimeric receptor complex of IL-17RA and IL17RC subunits, which recruits adaptor proteins Act1 (also known as TRAF3 interacting protein 2, TRAF3IP2) and TNF receptor associated factor 6 (TRAF6), and ultimately activates MAPK and NF-κB to regulate proinflammatory cytokines and chemokines expressio…”
BackgroundInfluentialTNFα-Signaling Modulates the Kinase Activity of Human Effector Treg and Regulates IL-17A Expression
Urbano, P. C. M., He, X., van Heeswijk, B., Filho, O. P. D. S., Tijssen, H. J., Smeets, R. L., Joosten, I., & Koenen, H. J. P. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03047 · Cited by 24
“TNFAIP3/A20 has been demonstrated to regulate critical proteins involved in TCR (23), TNFα (41), IL-17R (21), andWnt signaling (20, 42).”
BackgroundInfluentialPark, N., Park, S. J., Kim, M. H., & Yang, W. M. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153898 · Cited by 21
Murphy, S. F., Rhee, L., Grimm, W. A., Weber, C. R., Messer, J. S., Lodolce, J. P., Chang, J. E., Bartulis, S. J., Nero, T. M., Kukla, R. A., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00020.2014 · Cited by 22
Follistatin‐like protein 1 modulates IL‐17 signaling via IL‐17RC regulation in stromal cells
Campfield, B. T., Eddens, T. J., Henkel, M., Majewski, M., Horne, W. T., Chaly, Y., Gaffen, S. L., Hirsch, R., & Kolls, J. K. (2017) · Immunology and Cell Biology · doi:10.1038/icb.2017.26 · Cited by 27
Self-citationHarirchian, P., Lee, J., Hilz, S., Sedgewick, A. J., White, B. E. P., Kesling, M., Mully, T. W., Golovato, J., Gray, M., Mauro, T. M., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.10.046 · Cited by 21
The deubiquitinase A20 in immunopathology of autoimmune diseases
Majumdar, I., & Paul, J. (2014) · Autoimmunity · doi:10.3109/08916934.2014.900756 · Cited by 22
“[30] and involves both its OTU and C-terminal zinc finger domains.”
BackgroundPGRP negatively regulates NOD-mediated cytokine production in rainbow trout liver cells
Jang, J. H., Kim, H. J., Jang, M. J., & Cho, J. H. (2016) · Scientific Reports · doi:10.1038/srep39344 · Cited by 20
“For example, the deubiquitylating enzyme A20 is induced by IL-17 and mediates negative feedback by targeting TNF receptor-associated factor 6 (TRAF6) and thus reduces NF-κ B and MAPK signalling 38 .”
Kumaresan, V., Kamaraj, Y., Subramaniyan, S., & Punamalai, G. (2024) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-024-04893-8 · Cited by 23
“The termination of NF-kB signalling can be achieved by directly deactivating the upstream signalling molecules, such as TNF, interleukin 17 (IL-17), toll-like receptor 4 (TLR-4), and nucleotide-binding oligomerization domain-containing protein 2 (NOD2) [19, 48].”
USP24 stabilizes bromodomain containing proteins to promote lung cancer malignancy
Wang, S., Young, M.-J., Jeng, W. Y., Liu, C.-Y., & Hung, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-78000-2 · Cited by 20
Israël, L., Bardet, M., Huppertz, A., Mercado, N., Ginster, S., Unterreiner, A., Schlierf, A., Goetschy, J. F., Zerwes, H.-G., Roth, L., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.03.1503 · Cited by 18
“, 2008), which was independently shown to regulate IL-17R signaling in keratinocytes (Garg et al., 2013).”
BackgroundWu, J., Hu, J., Zhang, F., Jin, Q., & Sun, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108893 · Cited by 19
Shi, Y., Guo, Y., Zhou, J., Wu, L., Chen, L., Sun, Y., Li, T., Zhao, J., Bao, C., & Wu, H. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109149 · Cited by 18
CISH constrains the tuft–ILC2 circuit to set epithelial and immune tone
Kotas, M. E., Mroz, N. M., Koga, S., Liang, H.-E., Schroeder, A., Ricardo-González, R. R., Schneider, C., & Locksley, R. M. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00430-6 · Cited by 17
“However, apart from A20, which negatively regulates IL-25 signaling 9 , endogenous mechanisms that regulate ILC2 activity are less well characterized.”
IL-33 released during challenge phase regulates allergic asthma in an age-dependent way
Liu, H., Wu, M., Wang, Q., Gao, L., Jiang, H., Shi, K., Lin, Y., Zhou, J., Huang, J., Qu, S., et al. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01205-2 · Cited by 18
“All animal experiments were approved by the animal ethical committee of Huazhong University of Science and Technology.”
A novel missense mutation in TNFAIP3 causes haploinsufficiency of A20
Jiang, W. H., Deng, M., Gan, C., Wang, L., Mao, H., & Li, Q. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104453 · Cited by 17
Chitre, A. S., Kattah, M. G., Rosli, Y. Y., Pao, M., Deswal, M., Deeks, S. G., Hunt, P. W., Abdel‐Mohsen, M., Montaner, L. J., Kim, C. C., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006806 · Cited by 16
“Given the observation that IL-17A levels are restored to normal in ART-treated subjects (S1B and S1C Fig) and prior work in stromal cell lines showed that IL-17 signaling is restricted byA20 [49], we next tested whether A20 deletion altered the effects of IL-17A stimulation in organoid IECs.”
BackgroundSelf-citationIL‐17R deletion predicts high‐grade colorectal cancer and poor clinical outcomes
Yan, C. W., Huang, W., Boudreau, J. E., Mayavannan, A., Cheng, Z., & Wang, J. (2019) · International Journal of Cancer · doi:10.1002/ijc.32122 · Cited by 18
Garg, A. V., & Gaffen, S. L. (2013) · Cell Cycle · doi:10.4161/cc.26699 · Cited by 14
Self-citationIL-17RA in Intestinal Inflammation: Structure, Signaling, Function, and Clinical Application
Liu, S., Ren, J., & Li, J. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000217 · Cited by 14
“Garg et al(71) found that deubiquitinase A20 could interact with CBAD domain within IL-17RA, which further inhibits NF-kB activation and IL-6 transcription in an IL-17A–dependent manner.(71) Interestingly, Shi et al(72) found a novel desensitization mechanism of Act1 initiated by SCFb-TrCP to avoid persistent activati…”
BackgroundLi, H., Wu, Y., Huang, N., Zhao, Q., Yuan, Q., & Shao, B. (2020) · Current Gene Therapy · doi:10.2174/1566523220999200727122502 · Cited by 13
A Mechanistic Insight into the Pathogenic Role of Interleukin 17A in Systemic Autoimmune Diseases
Bisoendial, R. J., & Lubberts, E. (2022) · Mediators of Inflammation · doi:10.1155/2022/6600264 · Cited by 12
“Negative inhibitors of IL-17A signaling involve the deubiquitinase zinc-finger protein A20, a key player in the negative feedback regulation of NF-κB pathway, which is mediated via the CEBP beta activity domain (CBAD) [46].”
BackgroundRepressive Control of Keratinocyte Cytoplasmic Inflammatory Signaling
Carman, L. E., Samulevich, M. L., & Aneskievich, B. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511943 · Cited by 10
Daems, C., Sekulić, M., Vulsteke, V., Loo, G., D’Hooge, R., Callaerts‐Vegh, Z., & Callaerts, P. (2019) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2019.100018 · Cited by 12
“Besides an upregulation for Lcn2 (t10 ¼ 3.44, p ¼ 0.006) and C–”
BackgroundInfluentialSCFFBXW11 Complex Targets Interleukin-17 Receptor A for Ubiquitin–Proteasome-Mediated Degradation
Jin, B., Moududee, S. A., Ge, D., Zhou, P., Wang, A. R., Liu, Y., & You, Z. (2024) · Biomedicines · doi:10.3390/biomedicines12040755 · Cited by 9
“Recruitment of A20 to IL-17RA through the C/EBP β activation domain (CBAD) performs a negative feedback to deubiquitylate TRAF6, restricting IL-17-dependent activation of NF-κ B and MAPK signaling [22].”
BackgroundYan, C. W., Lei, Y., Lin, T., Hoskin, D. W., Ma, A. I., & Wang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.17820 · Cited by 9
“A20 also inhibits IRF-3-dependent gene production [26, 31], TNF-induced apoptosis and IL-17A-induced IL-6 production via inhibition of the JNK pathway [25, 32].”
BackgroundSelf-citationDabbah‐Krancher, G., Ruchinskas, A. J., Kallarakal, M. A., Lee, K. P., Bauman, B. M., Epstein, B. E., Yin, H., Krappmann, D., Schaefer, B. C., & Snow, A. L. (2024) · European Journal of Immunology · doi:10.1002/eji.202451245 · Cited by 8
“A20 is also a direct negative regulator of interleukin-1 receptor and IL-17R signaling, which can further boost the production of proinflam-matory cytokines such as IL-6, IL-1 β , and IL-17 if left unchecked [6, 71].”
Wassing, G. M., Ilehag, N., Frey, J., & Jonsson, A. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02002-20 · Cited by 8
Liu, X., Shao, L.-H., Chen, X., Wang, M., Qin, Q.-J., Yang, Y., Zhang, G., Yang, H. Y., & Tian, Y.-H. (2024) · Current Medical Science · doi:10.1007/s11596-024-2912-0 · Cited by 8
Metadata
- Authors
- Garg, A. V., Ahmed, M., Vallejo, A. N., Ma, A., & Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- University of California, San Francisco (US)
- Corresponding author
- Gaffen, Sarah L.
- Venue
- Science Signaling
- Published
- 2013-06-04
- Volume
- 6
- Issue
- 278
- Pages
- ra44-ra44
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- PMC
- PMC4028484
- OpenAlex
- W2103961090
- Cited by
- 128
- References
- 88
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 7 · 2023: 5 · 2022: 8 · 2021: 9 · 2020: 14 · 2019: 13 · 2018: 11 · 2017: 12 · 2016: 11 · 2015: 6 · 2014: 12 · 2013: 6
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science Signaling (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK095693, P30DK026743)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR054389, R01AR054389)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- A20, IL-17, IL-17 receptor signaling, TRAF6, E3 ubiquitin ligase, NF-κB activation, product inhibition, inflammatory cytokines, interleukin-6, chemokines, mitogen-activated protein kinase, autoimmunity, Th17 cells
- MeSH terms
- Humans, Promoter Regions, Genetic, Signal Transduction, NF-kappa B, TNF Receptor-Associated Factor 6, Receptors, Interleukin-17, Ubiquitin-Specific Proteases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.